AP NEWS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heron Therapeutics, Inc. (HRTX)

May 2, 2019

NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Heron Therapeutics, Inc. (“Heron” or the “Company”) (NASDAQ: HRTX). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/hrtx.

The investigation concerns whether Heron and certain of its officers and/or directors have violated federal securities laws.

On May 1, 2019, Heron announced receipt of a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) on April 30, 2019 regarding Heron’s New Drug Application (“NDA”) for HTX-011 for the management of postoperative pain. Heron advised investors that “[t]he CRL stated that the FDA is unable to approve the NDA in its present form based on the need for additional [Chemistry, Manufacturing, and Controls] and non-clinical information.” On this news, Heron’s stock price fell $3.93 per share, or 18.13%, to close at $17.75 per share on May 1, 2019.

If you are aware of any facts relating to this investigation, or purchased Heron shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/hrtx. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com